Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Which penny stocks are on your March 2022 watchlist as volatility continues? The post Are These Penny Stocks on Your Buy List Right Now?
WALTHAM, Mass., March 2, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that Mike Raab, president…
Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst Chris Howerton thinks Ardelyx "s
Ardelyx Inc (NASDAQ: ARDX ) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1 . Analyst Chris Howerton thinks Ardelyx "stands out" given that the Company has an approved IBS-C product, Isbrela, that will launch in April and whose commercial opportunity is validated by Linzess and Trulance. Ironwood Pharmaceuticals Inc (NASDAQ: IRWD ) and AbbVie Inc''s (NYSE: ABBV ) Linzess achieved $1 billion in sales in 2021, while Salix Pharmaceuticals'' Trulance achieved … Full story available on Benzinga.com

Penny Stocks Under $1 To Watch In March 2022

05:13pm, Wednesday, 02'nd Mar 2022 PennyStocks
Penny stocks to buy for under $1. The post Penny Stocks Under $1 To Watch In March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Benzinga's Top Ratings Upgrades, Downgrades For March 2, 2022

03:32pm, Wednesday, 02'nd Mar 2022 Benzinga
Upgrades Barclays upgraded the previous rating for Equitrans Midstream Corp (NYSE:ETRN) from Underweight to Equal-Weight. Equitrans Midstream earned $0.07 in the fourth quarter, compared to $0.31 in

ARDX stock rises on Jefferies upgrade (NASDAQ:ARDX)

02:28pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Micro-cap biotech Ardelyx (ARDX) is trading ~11% higher in the pre-market on Wednesday after Jefferies analyst Christopher Howerton upgraded the stock to Buy from Hold citing…
Ardelyx Inc (NASDAQ: ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target on the stock to $5 from $1. Analyst Chris Howerton thinks Ardelyx "s

28 Stocks Moving in Wednesday''s Pre-Market Session

12:15pm, Wednesday, 02'nd Mar 2022 Benzinga
Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI ) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11 million public offering. CooTek (Cayman) Inc. (NYSE: CTK ) rose 37% to $0.4387 in pre-market trading after gaining over 36% on Tuesday. Nordstrom, Inc. (NYSE: JWN ) rose 32.1% to $25.81 in pre-market trading after reporting better-than-expected quarterly results. ECMOHO Limited (NASDAQ: MOHO ) rose 28.8% to $0.30 in pre-market trading after jumping 10% on Tuesday. Avenue Therapeutics, Inc. (NASDAQ: ATXI ) rose 26.9% to $0.77 in pre-market trading after jumping 78% on Tuesday. Avenue Therapeutics, last month, announced the outcome of the FDA meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee on IV tramadol. Brickell Biotech, Inc. (NASDAQ: BBI ) rose 26% to $0.2741 in pre-market trading after gaining around 4% on Tuesday.

Penny Stocks Under $1 To Watch In March 2022

12:13pm, Wednesday, 02'nd Mar 2022
Penny stocks to buy for under $1. The post Penny Stocks Under $1 To Watch In March 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Ardelyx (ARDX) Reports Q4 Loss, Misses Revenue Estimates

10:55pm, Monday, 28'th Feb 2022 Zacks Investment Research
Ardelyx (ARDX) delivered earnings and revenue surprises of -24% and 48.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Ardelyx press release (ARDX): Q4 GAAP EPS of -$0.31 misses by $0.05.Revenue of $1.03M (-44.4% Y/Y) beats by $0.12M.
WALTHAM, Mass., Feb. 28, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today reported business events and financial…
Ardelyx, Inc. (ARDX) CEO Mike Raab on Q4 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE